Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: AI-Enhanced Wide-Field Endoscopic Fluorescence Mapping of Gastrointestinal Mucosal Permeability in IBD - A Pilot Study in IBD Patients and Controls
This pilot clinical trial examines AI-enhanced wide-field endoscopic fluorescence mapping to evaluate gastrointestinal mucosal permeability …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease [NA]
A clinical trial is evaluating the effect of the probiotic preparation VSL#3 on bile acid metabolism in patients with inflammatory bowel dis…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Multi-omics Dissection of Gut Microbiome Engraftment During FMT [NA]
Clinical trial update for a NOT_YET_RECRUITING study examining gut microbiome engraftment during fecal microbiota transplantation in recurre…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update describes BCMA-CD19 cCAR T therapy for refractory inflammatory bowel disease, with trial status NOT_YET_RE…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting [Phase 4]
Phase 4 clinical trial update for Vedolizumab in adults with Ulcerative colitis or Crohn's disease in the community setting; the study is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial is evaluating LY4268989 in adults with moderately to severely active ulcerative colitis and is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT） [Phase 4]
A Phase 4 clinical trial is evaluating the comparative effectiveness of upadacitinib versus corticosteroids as initial therapy for acute sev…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) [Phase 2]
Phase 2 clinical trial MK-8690-002 evaluating efficacy and safety of MK-8690 in moderately to severely active ulcerative colitis is currentl…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
This completed clinical trial evaluated physical fitness levels in children and adolescents with chronic inflammatory bowel disease, includi…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
This is a real-world clinical trial in Saudi Arabia evaluating guselkumab for ulcerative colitis and Crohn's disease, with status not yet re…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
An observational prospective long-term exposure registry sponsored by Janssen Biotech to monitor safety and real-world use in adults with mo…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe [NA]
Massachusetts General Hospital reports an ongoing clinical trial using a colonoscope-compatible thermal probe to measure gut temperature in …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) [Phase 3]
This clinical trial update describes the Phase 3 LUCENT 3 study evaluating the long-term efficacy and safety of mirikizumab in participants …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis [Phase 2]
Phase 2 study evaluating Eltrekibart and Mirikizumab in adults with moderately to severely active Ulcerative Colitis; the trial is currently…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Confirmatory Clinical Study in Active Ulcerative Colitis [Phase 2]
Phase 2 confirmatory clinical study in active ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2) [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of IPG11406 in moderately to severely active ulcerative colitis. The study st…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: [Phase 2]
A Phase 2 clinical trial evaluating LY4268989 (MORF-057) in combination with mirikizumab for adults with moderately to severely active ulcer…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
The COMPARE trial for pediatric inflammatory bowel disease is currently recruiting, evaluating treatments for pediatric ulcerative colitis a…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis [Phase 1, Phase 2]
Genentech is conducting a Phase 1/2 clinical trial to evaluate the activity and safety of Vixarelimab in participants with moderate to sever…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study [Phase 3]
A Phase 3b trial is evaluating concurrent administration of mirikizumab with tirzepatide in adults with moderately to severely active ulcera…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) [Phase 3]
This is a Phase 3 master protocol study (SHINE-ON) evaluating Mirikizumab (LY3074828) in pediatric participants with Ulcerative colitis or C…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants [Phase 1]
This Phase 1 clinical trial update describes the evaluation of LYNC-101 for injection in healthy adults, focusing on safety, tolerability, p…
-
EMA approval · 2026-04-16EMA Authorised: Qoyvolma (ustekinumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Qoyvolma (ustekinumab) by Celltrion Healthcare Hungary Kft. for psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC) [Phase 1, Phase 2]
The Cleveland Clinic-sponsored study evaluating mesenchymal stem cells for medically refractory ulcerative colitis in phase 1/2 has been ter…